These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11599032)

  • 41. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.
    Rock JP; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rosenblum M; Mikkelsen T
    Neurosurgery; 2004 May; 54(5):1111-7; discussion 1117-9. PubMed ID: 15113465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Burtscher IM; Ståhlberg F; Holtås S
    Acta Radiol; 1997 Nov; 38(6):953-60. PubMed ID: 9394648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
    Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
    Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children.
    Holshouser BA; Ashwal S; Luh GY; Shu S; Kahlon S; Auld KL; Tomasi LG; Perkin RM; Hinshaw DB
    Radiology; 1997 Feb; 202(2):487-96. PubMed ID: 9015079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.
    Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Bonavita S; de Cristofaro M; Conforti R; Cristofano A; Colonnese C; Salvolini U; Tedeschi G
    Radiol Med; 2014 Aug; 119(8):616-24. PubMed ID: 24408041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
    Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
    Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
    Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S
    Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.
    Sappey-Marinier D; Calabrese G; Hetherington HP; Fisher SN; Deicken R; Van Dyke C; Fein G; Weiner MW
    Magn Reson Med; 1992 Aug; 26(2):313-27. PubMed ID: 1513253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
    Wilken B; Dechent P; Herms J; Maxton C; Markakis E; Hanefeld F; Frahm J
    Pediatr Neurol; 2000 Jul; 23(1):22-31. PubMed ID: 10963966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain tumors: localized H-1 MR spectroscopy at 0.5 T.
    Prost R; Haughton V; Li SJ
    Radiology; 1997 Jul; 204(1):235-8. PubMed ID: 9205253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.